Shares of Health Care sector company Rhythm Pharmaceuticals moved 2.4% today, and are now trading at a price of $37.69. The small-cap stock's daily volume was 1,101,846 compared to its average volume of 587,419. The S&P 500 index returned a -0.0% performance.
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company is based in Boston and has 177 full time employees. Its market capitalization is $2,227,346,944.
9 analysts are following Rhythm Pharmaceuticals and have set target prices ranging from $29.0 to $70.0 per share. On average, they have given the company a rating of buy. At today's prices, RYTM is trading -7.08% away from its average analyst target price of $40.56 per share.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | -140,774 | 47 | -140,821 | 18.93 |
| 2022 | -173,428 | 281 | -173,709 | -18.62 |
| 2021 | -146,003 | 434 | -146,437 | -19.97 |
| 2020 | -121,980 | 84 | -122,064 | 3.23 |
| 2019 | -122,750 | 3,385 | -126,135 | -101.97 |
| 2018 | -62,056 | 395 | -62,451 |
